Literature DB >> 6108337

Characterization of radiolabeled agonist binding to beta-adrenergic receptors in mammalian tissues.

K A Heidenreich, G A Weiland, P B Molinoff.   

Abstract

Recent evidence suggests that the molecular interactions of agonists with beta-adrenergic receptors differ from those of antagonists. Most of this evidence has come from studies of agonist inhibition of radiolabeled antagonist binding. We have examined agonist binding directly in rat lung membranes using radiolabeled hydroxybenzylisoproterenol (3H-HBI). Specific binding of 3H-HBI was stereoselective and was inhibited by catecholamines with a potency order characteristic of beta 2-adrenergic receptors. Gpp(NH)p increased the rates of association and dissociation of 3H-HBI from the receptor. In the absence of Gpp(NH)p, Scatchard plots were curvilinear suggesting a complex interaction of the agonist with the receptor. The total number of 3H-HBI binding sites was similar to that of 125I-IHYP binding sites. In the presence of increasing concentrations of Gpp(NH)p, the affinity of 3H-HBI was decreased and Scatchard plots became linear. Sodium chloride mimicked the effect of Gpp(NH)p in lowering the affinity of the receptor for 3H-HBI. Magnesium chloride had the opposite effect in that it promoted high affinity binding. The effect of sodium chloride was largely overcome by the presence of magnesium chloride.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6108337

Source DB:  PubMed          Journal:  J Cyclic Nucleotide Res        ISSN: 0095-1544


  7 in total

1.  Properties of agonist binding at the beta-adrenoceptor of the rat reticulocyte.

Authors:  G Wiemer; A Wellstein; D Palm; H M von Hattingberg; D Brockmeier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-10       Impact factor: 3.000

2.  Binding characteristics of (+)-, (+/-)- and (-)-[125iodo] cyanopindolol to guinea-pig left ventricle membranes.

Authors:  D Hoyer; G Engel; R Berthold
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-03       Impact factor: 3.000

3.  Carbostyril-based beta-adrenergic agonists: evidence for long lasting or apparent irreversible receptor binding and activation of adenylate cyclase activity in vitro.

Authors:  K M Standifer; J Pitha; S P Baker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

4.  Agonist binding at alpha 2-adrenoceptors of human platelets using 3H-UK-14,304: regulation by Gpp(NH)p and cations.

Authors:  J Schloos; A Wellstein; D Palm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

5.  Solubilization and reconstitution of dopamine D1 receptor from bovine striatal membranes: effects of agonist and antagonist pretreatment.

Authors:  L K Srivastava; G M Ross; S B Bajwa; R K Mishra
Journal:  Neurochem Res       Date:  1990-06       Impact factor: 3.996

6.  Sodium regulation of agonist and antagonist binding to beta-adrenoceptors in intact and Ns-deficient membranes.

Authors:  M Minuth; K H Jakobs
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-06       Impact factor: 3.000

7.  Rate-limiting steps in the beta-adrenergic stimulation of cardiac calcium current.

Authors:  A M Frace; P F Méry; R Fischmeister; H C Hartzell
Journal:  J Gen Physiol       Date:  1993-03       Impact factor: 4.086

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.